Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma
Benjamin S Gerendash,1 Patricia A Creel2 1Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, 2Oncology, Clinical Operations, Duke University Medical Center, Durham, NC, USA Abstract: Cabozantinib is an oral tyrosine-kinase inhibitor...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-10-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/practical-management-of-adverse-events-associated-with-cabozantinib-tr-peer-reviewed-article-OTT |